Categories
Price Data
NASDAQELOS

Overview

Syneron Medical Ltd. (NASDAQ: ELOS) is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.

The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring,  hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Additional information can be found at www.syneron-candela.com

 

Syneron Investor Presentation February 2015
Syneron Investor Presentation February 2015 (2.7 MB)

 
Syneron Events
Wednesday, May 13, 2015
8:30am EDT

Syneron management will host a conference call and a live webcast at8:30 a.m. (ET) on the same day. A question & answer session will follow management's discussion of events in the first quarter 2015.

Thursday, February 12, 2015
11:35am EST

Sarit Soccary Ben Yochanan, Vice President of Business Development and Strategy, and Brian Hayes, Vice President of Body Shaping Group, are scheduled to participate in the 2015 Leerink Global...

See calendar


print email